3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
3
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Head & Neck
2
Lymphoid
1
Conditions
Head and Neck Neoplasms
2106
Squamous Cell Carcinoma of Head and Neck
1654
Nasopharyngeal Carcinoma
517
Thyroid Neoplasms
478
Carcinoma, Non-Small-Cell Lung
438
Breast Neoplasms
315
Mouth Neoplasms
312
Neoplasms
310
Melanoma
299
Oropharyngeal Neoplasms
285
Colorectal Neoplasms
275
Lung Neoplasms
248
Carcinoma, Squamous Cell
240
Neoplasm Metastasis
235
Ovarian Neoplasms
229
Uterine Cervical Neoplasms
205
Stomach Neoplasms
196
Salivary Gland Neoplasms
192
Laryngeal Neoplasms
192
Nasopharyngeal Neoplasms
189
Carcinoma, Renal Cell
183
Esophageal Neoplasms
179
Pancreatic Neoplasms
177
Prostatic Neoplasms
158
Sarcoma
142
Triple Negative Breast Neoplasms
136
Urinary Bladder Neoplasms
135
Recurrence
128
Endometrial Neoplasms
125
Hypopharyngeal Neoplasms
121
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Sjogren's Syndrome
×
Head & Neck
×
Clear all
NCT07290946
2025-12-18
MESRIX-more
Rigshospitalet, Denmark
Phase 2
Not yet recruiting
100 enrolled
NCT02049112
2014-01-29
NIAGARA
Unither Pharmaceuticals, France
Phase 4
Completed
210 enrolled